Elizabeth Mily, BMS business development chief
Bristol Myers to spend $50B on deals, buybacks in next 3 years — although BD chief notes finding the right deal still 'very hard'
Bristol Myers Squibb has loaded up plenty of ammunition for M&A and other types of deals over the next two years — even if the right …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
